ADA Home Page
Licensure | Catalog | Member Directory | Contact  
 
Dental Professionals Your Oral Health The ADA
A to Z Topics
Advocacy
Education
Events
Member Center
Publications and Resources
ADA LIBRARY
ADA PUBLICATIONS
About ADA Publishing
ADA News Today
Advertise in
ADA Publications
Advocacy Publications
Buying Guide
Classifieds
E-Publications/E-mail
Journal of the ADA
Subscribe
Professional Product Review
DENTAL CAREERS AND
JOB LISTINGS
EVIDENCE BASED DENTISTRY
PODCASTS
ADA POLICIES & POSITIONS
STANDARDS
Practice Planning and Protection


the journal of the American dental association
  About JADA   JADA Online Site License Program
  Advertise in ADA Publications Link opens in separate window. Pop-up Blocker may need to be disabled.   International Editions
  Author Guidelines   Letters Submissions
  Classified Advertising   Manuscript Submissions
  Contact JADA Link opens in separate window. Pop-up Blocker may need to be disabled.   Permissions/Reprints
  Continuing Education Program   Supplements & Special Reports
  Editorial Board and Staff Directory Link opens in separate window. Pop-up Blocker may need to be disabled.   Go to JADA Online Link opens in separate window. Pop-up Blocker may need to be disabled.
  For the Dental Patient  

Continuing Education Program — January 2008

Article 1: Incidence of Osteonecrosis of the Jaw in Women With Postmenopausal Osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial Link opens in separate window. Pop-up Blocker may need to be disabled.

1. Approximately what proportion of people experiencing hip fractures die within one year of the fracture?

2. Which one of the following statements about the two participants who had a lesion that met the study’s definition of osteonecrosis of the jaw is correct?

3. What was the change in risk of experiencing vertebral fractures over the three years of the study among women who received zoledronic acid?

4. What was the change in risk of experiencing hip fractures over the three years of the study among women who received zoledronic acid?

Article 2: The Changing Spectrum of Clostridium difficile–Associated Disease: Implications for Dentistry Link opens in separate window. Pop-up Blocker may need to be disabled.

1. Which one of the following is not a characteristic of the Clostridium difficile bacillus?

2. Which one of the following correctly describes the change in the rate of C. difficile-associated disease (CDAD) in the United States between 1996 and 2003?

3. Approximately what percentage of C. difficile infections occur during or after antimicrobial therapy?

4. Which one of the following oral medications would be an appropriate component of medical treatment for a patient with a mild-to-moderate CDAD?

Article 3: Application of a Dental Adhesive Using the Self-Etch and Etch-and-Rinse Approaches: An 18-month Clinical Evaluation Link opens in separate window. Pop-up Blocker may need to be disabled.

1. Which group had the highest retention rate after 18 months?

2. Which group had the lowest retention rate after 18 months?

3. Which group had the highest rate of marginal discoloration at 18 months?

4. Which group had the highest rate of postoperative sensitivity at 18 months?

Article 4: Using a Caries Activity Test to Predict Caries Risk in Early Childhood Link opens in separate window. Pop-up Blocker may need to be disabled.

1. Which one of the following is the lowest 18-month caries activity score associated with a 2-year-old caries prevalence of 10 percent or greater?

2. Which one of the following is the lowest 18-month caries activity score associated with a 3-1/2-year old caries prevalence greater than 30 percent?

3. Which one of the following is the lowest 2-year caries activity score associated with a 3-1/2-year old caries prevalence greater than 40 percent?

4. Which one of the following items from the questionnaire was significantly related to the caries experience of 18-month old children?

To submit your test answers, click the "Submit" button below. The JADA CE payment screen on the University of Colorado Health Sciences Center Web site will open in a new window. Following payment, confirmation of the credits you've earned will be displayed for printing. An additional confirmation will be sent by e-mail and postal mail.

Please note, you will not have the opportunity to revise your answers once you've submitted the test.

Quick Links
Subscribe to JADA
ADA Research Agenda
Advertise in JADA
Publishing Division Editorial Policies
Copyright 1995-2008 American Dental Association.
Reproduction or republication strictly prohibited without prior written permission.
See Privacy Policy (Updated 03/14/05) and Terms of Use for further legal information.
Link opens in separate window. Pop-up Blocker may need to be disabled. Link opens in separate window.
Pop-up Blocker may need to be disabled.
Member Only Content Member only content.